NRG Oncology awarded NCI funding for next 6 years, receives ‘exceptional’ score
NRG Oncology, a National Cancer Institute (NCI) National Clinical Trials Network (NCTN) group conducting practice-changing clinical and translational research, has been awarded funding of over $95 Million by the NCI for the next six years to continue its work as a lead protocol organization (LPO) program. During the peer review grant renewal process, NRG Oncology…